Recombinant Proteins Market Key Players Analysis, and Growth Forecast by 2031

Coverage: Recombinant Proteins Market covers analysis By Product (Hormones, Cytokines, Plasma Protein Factor, Growth Factors, Recombinant Metabolic Enzymes and Others); Application (Drug Discovery & Development, Biopharmaceutical Production, Basic Research and Others); End User (Biopharmaceutical Companies, Academic & Research Institutes, Contract Research Organizations and Others) , and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Code : TIPRE00003725
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Recombinant Proteins Market SWOT and PEST Analysis 2021-2031

Buy Now

The Recombinant Proteins Market is expected to register a CAGR of 10.10% from 2024 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.

The Recombinant Proteins Market report covers analysis By Product; Application; and End User. The global analysis is further broken down at the regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.

Purpose of the Report

The report Recombinant Proteins Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  • Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  • Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  • Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Recombinant Proteins Market Segmentation

Product
  • Hormones
  • Cytokines
  • Plasma Protein Factor
  • Growth Factors
  • Recombinant Metabolic Enzymes and Others
Application
  • Drug Discovery & Development
  • Biopharmaceutical Production
  • Basic Research and Others
End User
  • Biopharmaceutical Companies
  • Academic & Research Institutes
  • Contract Research Organizations and Others
Geography
  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Strategic Insights

Recombinant Proteins Market Growth Drivers
  • Focus on precision medicine boosts demand: Increased focus on precision medicine and biopharmaceuticals facilitate growth in the recombinant proteins market size, as these proteins are an important drug development prerequisite; targeted therapies also depend on them. According to reports, it is noticed that the shifting focus toward personalized treatments boosts the demand for high-quality recombinant proteins. This gets further agreement through competitive analysis that pharmaceutical companies invest in recombinant proteins to meet the standards of precision medicine and hence contribute to the growth of the global market, furthering the industry.
  • Genetic engineering and biotechnology drive growth: The key drivers in the recombinant proteins market are genetic engineering and biotechnology. On the other hand, research into molecular biology and gene editing has been driving demand for recombinant proteins in drug discovery, diagnostics, and many more. It is gathered from market analysis and PEST factors that drive innovation and therapeutic breakthroughs supportive of the growth of the market. This progress, therefore, furthers the recombinant proteins market, its continuing expansion opening up ways for breakthroughs across numerous medical fields.
  • Rising chronic diseases increase protein demand: The rising prevalence of chronic diseases, including cancer, diabetes, and autoimmune disorders, has contributed to the market size growth of recombinant proteins. Recombinant proteins are important in developing treatments for these conditions and increasing demand globally. The Recombinant Proteins Market trend is such that with increases in chronic diseases worldwide, the demands for targeted, effective treatments increase. Because of this, market reports estimate that this growing demand will drive the market and further induce innovation in protein therapeutics to firmly establish the global Recombinant Proteins Market position of recombinant proteins.
Recombinant Proteins Market Future Trends
  • Shift to E. coli, yeast expression systems: The recombinant proteins market is shifting toward expression systems based on E. coli and yeast because of the efficacy and lesser cost of production for such systems. Key players in the market are finding these systems to attempt optimization of production methods. Market dynamics indicate that these expression systems are becoming increasingly popular because they can be scaled up and turnaround time is quick. Forecast data from the market illustrates this as a trend that shapes strategies while companies work to improve productivity and reduce costs to meet demand in the biotechnology sector.
  • Heavy investment in R&D for therapeutics: One of the key trends in the recombinant proteins market is the increasing investment in R&D regarding new protein therapeutics. The leading companies in the industry are investing heavily in the development of novel protein-based treatments. Market estimates reveal that such a strong emphasis on R&D will result in a strong increase in Recombinant Proteins Market dynamics and give an advantage to firms leading in the research of proteins at a competitive level. SWOT analysis underlines R&D as a priority area for further market development where new protein therapeutics will boost future demand
  • E-commerce increasing protein access globally: The market for recombinant proteins is influenced by the growing use of e-commerce for procuring research products that enable access to these proteins in easier and quicker ways than earlier for large numbers of researchers around the world. Recombinant Proteins Market dynamics seem to indicate that digital sales channels are increasing the reach of key players, especially in remote or emerging markets. Forecasts in the market would suggest that online sales are projected to continue increasing into the future, where the marketing strategy would now focus on digital platforms for accessibility in meeting the increased demand for recombinant proteins across the world.
Recombinant Proteins Market Opportunities
  • Growth opportunities in North America, Europe: The established biopharmaceutical sectors in North America and Europe offer huge growth prospects for the recombinant proteins market. Having advanced research facilities and large investments in drug development, these regions present promising markets for recombinant proteins. An overview of the market dynamics across these regions suggests that companies that aim at compliance with regulatory standards in these areas are more likely to have considerable market share. Expanding into mature markets is aligned with the demand for therapeutic and research applications; thus, it presents solid growth potential.
  • Biopharma sector growth in Asia-Pacific: An up-and-coming opportunity for the recombinant protein market is provided by the fast-growing biopharma sector in the Asia-Pacific region. Increasing investment in health infrastructure, coupled with escalating R&D initiatives, forms the basis of observation from Recombinant Proteins Market analysis where high demand is witnessed to be generated for the molecule type in focus from this region. The reports on the industry landscape indicate that companies establishing their presence in the Asia-Pacific region are most likely to hold a competitive edge since this geography provides huge market share potential arising from its sectors of biopharmaceuticals and research.
  • Custom recombinant proteins for research needs: Specialty research application needs are increasingly in need of custom recombinant proteins; hence, the niche growth opportunity. Market overview: there has been growth in the increasing demand for targeted research applications, including cancer and genetic studies, and there is a rise in the need for specific protein solutions. Those companies capable of offering tailored proteins toward the fulfillment of every research need will have the ability to attain a unique Recombinant Proteins Market share in meeting the requirements of academic and clinical institutions focused on innovative therapeutic applications.

Market Report Scope

Key Selling Points

  • Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Recombinant Proteins Market, providing a holistic landscape.
  • Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
  • Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
  • Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

The research report on the Recombinant Proteins Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.

REGIONAL FRAMEWORK
World Geography

Have a question?

Analyst

Mrinal

Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst   Speak to Analyst
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
MARKET PLAYERS
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are the deliverable formats of Recombinant Proteins Market report?

The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.

What are the options available for the customization of this report?

Some of the customization options available based on request are additional 3-5 company profiles and country-specific analysis of 3-5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.

Which are the key players in the Recombinant Proteins Market?

Key companies of this market are: Crown Bioscience Inc., Prospec-Tany Technogene Ltd., BPS Bioscience, Inc., Novoprotein, PeproTech, Inc., Eli Lilly and Company, Merck & Co., Inc., Proteintech Group, GenScript, GlaxoSmithKline plc.

What are the future trends in the Recombinant Proteins Market?

Key future trends in this market are - Growth in pharmaceutical research, Increased use in vaccine development, Rise in personalized medicine applications

What is the expected CAGR of the Recombinant Proteins Market?

The Recombinant Proteins Market is expected to register a CAGR of 10.10% from 2023-2031.

What are the driving factors impacting the Recombinant Proteins Market?

The major factors impacting the Recombinant Proteins Market are: Growing Demand for Biopharmaceuticals and Precision Medicine, Increased Research in Genetic Engineering and Biotechnology, and Rising Prevalence of Chronic Diseases

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Recombinant Proteins Market - By Product
1.3.2 Recombinant Proteins Market - By Application
1.3.3 Recombinant Proteins Market - By End User
1.3.4 Recombinant Proteins Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. RECOMBINANT PROTEINS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. RECOMBINANT PROTEINS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. RECOMBINANT PROTEINS MARKET - GLOBAL MARKET ANALYSIS
6.1. RECOMBINANT PROTEINS - GLOBAL MARKET OVERVIEW
6.2. RECOMBINANT PROTEINS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. RECOMBINANT PROTEINS MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. HORMONES
7.3.1. Overview
7.3.2. Hormones Market Forecast and Analysis
7.4. CYTOKINES
7.4.1. Overview
7.4.2. Cytokines Market Forecast and Analysis
7.5. PLASMA PROTEIN FACTOR
7.5.1. Overview
7.5.2. Plasma Protein Factor Market Forecast and Analysis
7.6. GROWTH FACTORS
7.6.1. Overview
7.6.2. Growth Factors Market Forecast and Analysis
7.7. RECOMBINANT METABOLIC ENZYMES
7.7.1. Overview
7.7.2. Recombinant Metabolic Enzymes Market Forecast and Analysis
7.8. AND OTHERS
7.8.1. Overview
7.8.2. and Others Market Forecast and Analysis
8. RECOMBINANT PROTEINS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. DRUG DISCOVERY AND DEVELOPMENT
8.3.1. Overview
8.3.2. Drug Discovery and Development Market Forecast and Analysis
8.4. BIOPHARMACEUTICAL PRODUCTION
8.4.1. Overview
8.4.2. Biopharmaceutical Production Market Forecast and Analysis
8.5. BASIC RESEARCH
8.5.1. Overview
8.5.2. Basic Research Market Forecast and Analysis
8.6. AND OTHERS
8.6.1. Overview
8.6.2. and Others Market Forecast and Analysis
9. RECOMBINANT PROTEINS MARKET - REVENUE AND FORECASTS TO 2028 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. BIOPHARMACEUTICAL COMPANIES
9.3.1. Overview
9.3.2. Biopharmaceutical Companies Market Forecast and Analysis
9.4. ACADEMIC AND RESEARCH INSTITUTES
9.4.1. Overview
9.4.2. Academic and Research Institutes Market Forecast and Analysis
9.5. CONTRACT RESEARCH ORGANIZATIONS
9.5.1. Overview
9.5.2. Contract Research Organizations Market Forecast and Analysis
9.6. OTHERS
9.6.1. Overview
9.6.2. Others Market Forecast and Analysis
10. RECOMBINANT PROTEINS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Recombinant Proteins Market Overview
10.1.2 North America Recombinant Proteins Market Forecasts and Analysis
10.1.3 North America Recombinant Proteins Market Forecasts and Analysis - By Product
10.1.4 North America Recombinant Proteins Market Forecasts and Analysis - By Application
10.1.5 North America Recombinant Proteins Market Forecasts and Analysis - By End User
10.1.6 North America Recombinant Proteins Market Forecasts and Analysis - By Countries
10.1.6.1 United States Recombinant Proteins Market
10.1.6.1.1 United States Recombinant Proteins Market by Product
10.1.6.1.2 United States Recombinant Proteins Market by Application
10.1.6.1.3 United States Recombinant Proteins Market by End User
10.1.6.2 Canada Recombinant Proteins Market
10.1.6.2.1 Canada Recombinant Proteins Market by Product
10.1.6.2.2 Canada Recombinant Proteins Market by Application
10.1.6.2.3 Canada Recombinant Proteins Market by End User
10.1.6.3 Mexico Recombinant Proteins Market
10.1.6.3.1 Mexico Recombinant Proteins Market by Product
10.1.6.3.2 Mexico Recombinant Proteins Market by Application
10.1.6.3.3 Mexico Recombinant Proteins Market by End User
10.2. EUROPE
10.2.1 Europe Recombinant Proteins Market Overview
10.2.2 Europe Recombinant Proteins Market Forecasts and Analysis
10.2.3 Europe Recombinant Proteins Market Forecasts and Analysis - By Product
10.2.4 Europe Recombinant Proteins Market Forecasts and Analysis - By Application
10.2.5 Europe Recombinant Proteins Market Forecasts and Analysis - By End User
10.2.6 Europe Recombinant Proteins Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Recombinant Proteins Market
10.2.6.1.1 Germany Recombinant Proteins Market by Product
10.2.6.1.2 Germany Recombinant Proteins Market by Application
10.2.6.1.3 Germany Recombinant Proteins Market by End User
10.2.6.2 France Recombinant Proteins Market
10.2.6.2.1 France Recombinant Proteins Market by Product
10.2.6.2.2 France Recombinant Proteins Market by Application
10.2.6.2.3 France Recombinant Proteins Market by End User
10.2.6.3 Italy Recombinant Proteins Market
10.2.6.3.1 Italy Recombinant Proteins Market by Product
10.2.6.3.2 Italy Recombinant Proteins Market by Application
10.2.6.3.3 Italy Recombinant Proteins Market by End User
10.2.6.4 Spain Recombinant Proteins Market
10.2.6.4.1 Spain Recombinant Proteins Market by Product
10.2.6.4.2 Spain Recombinant Proteins Market by Application
10.2.6.4.3 Spain Recombinant Proteins Market by End User
10.2.6.5 United Kingdom Recombinant Proteins Market
10.2.6.5.1 United Kingdom Recombinant Proteins Market by Product
10.2.6.5.2 United Kingdom Recombinant Proteins Market by Application
10.2.6.5.3 United Kingdom Recombinant Proteins Market by End User
10.2.6.6 Rest of Europe Recombinant Proteins Market
10.2.6.6.1 Rest of Europe Recombinant Proteins Market by Product
10.2.6.6.2 Rest of Europe Recombinant Proteins Market by Application
10.2.6.6.3 Rest of Europe Recombinant Proteins Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Recombinant Proteins Market Overview
10.3.2 Asia-Pacific Recombinant Proteins Market Forecasts and Analysis
10.3.3 Asia-Pacific Recombinant Proteins Market Forecasts and Analysis - By Product
10.3.4 Asia-Pacific Recombinant Proteins Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Recombinant Proteins Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Recombinant Proteins Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Recombinant Proteins Market
10.3.6.1.1 Australia Recombinant Proteins Market by Product
10.3.6.1.2 Australia Recombinant Proteins Market by Application
10.3.6.1.3 Australia Recombinant Proteins Market by End User
10.3.6.2 China Recombinant Proteins Market
10.3.6.2.1 China Recombinant Proteins Market by Product
10.3.6.2.2 China Recombinant Proteins Market by Application
10.3.6.2.3 China Recombinant Proteins Market by End User
10.3.6.3 India Recombinant Proteins Market
10.3.6.3.1 India Recombinant Proteins Market by Product
10.3.6.3.2 India Recombinant Proteins Market by Application
10.3.6.3.3 India Recombinant Proteins Market by End User
10.3.6.4 Japan Recombinant Proteins Market
10.3.6.4.1 Japan Recombinant Proteins Market by Product
10.3.6.4.2 Japan Recombinant Proteins Market by Application
10.3.6.4.3 Japan Recombinant Proteins Market by End User
10.3.6.5 South Korea Recombinant Proteins Market
10.3.6.5.1 South Korea Recombinant Proteins Market by Product
10.3.6.5.2 South Korea Recombinant Proteins Market by Application
10.3.6.5.3 South Korea Recombinant Proteins Market by End User
10.3.6.6 Rest of Asia-Pacific Recombinant Proteins Market
10.3.6.6.1 Rest of Asia-Pacific Recombinant Proteins Market by Product
10.3.6.6.2 Rest of Asia-Pacific Recombinant Proteins Market by Application
10.3.6.6.3 Rest of Asia-Pacific Recombinant Proteins Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Recombinant Proteins Market Overview
10.4.2 Middle East and Africa Recombinant Proteins Market Forecasts and Analysis
10.4.3 Middle East and Africa Recombinant Proteins Market Forecasts and Analysis - By Product
10.4.4 Middle East and Africa Recombinant Proteins Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Recombinant Proteins Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Recombinant Proteins Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Recombinant Proteins Market
10.4.6.1.1 South Africa Recombinant Proteins Market by Product
10.4.6.1.2 South Africa Recombinant Proteins Market by Application
10.4.6.1.3 South Africa Recombinant Proteins Market by End User
10.4.6.2 Saudi Arabia Recombinant Proteins Market
10.4.6.2.1 Saudi Arabia Recombinant Proteins Market by Product
10.4.6.2.2 Saudi Arabia Recombinant Proteins Market by Application
10.4.6.2.3 Saudi Arabia Recombinant Proteins Market by End User
10.4.6.3 U.A.E Recombinant Proteins Market
10.4.6.3.1 U.A.E Recombinant Proteins Market by Product
10.4.6.3.2 U.A.E Recombinant Proteins Market by Application
10.4.6.3.3 U.A.E Recombinant Proteins Market by End User
10.4.6.4 Rest of Middle East and Africa Recombinant Proteins Market
10.4.6.4.1 Rest of Middle East and Africa Recombinant Proteins Market by Product
10.4.6.4.2 Rest of Middle East and Africa Recombinant Proteins Market by Application
10.4.6.4.3 Rest of Middle East and Africa Recombinant Proteins Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Recombinant Proteins Market Overview
10.5.2 South and Central America Recombinant Proteins Market Forecasts and Analysis
10.5.3 South and Central America Recombinant Proteins Market Forecasts and Analysis - By Product
10.5.4 South and Central America Recombinant Proteins Market Forecasts and Analysis - By Application
10.5.5 South and Central America Recombinant Proteins Market Forecasts and Analysis - By End User
10.5.6 South and Central America Recombinant Proteins Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Recombinant Proteins Market
10.5.6.1.1 Brazil Recombinant Proteins Market by Product
10.5.6.1.2 Brazil Recombinant Proteins Market by Application
10.5.6.1.3 Brazil Recombinant Proteins Market by End User
10.5.6.2 Argentina Recombinant Proteins Market
10.5.6.2.1 Argentina Recombinant Proteins Market by Product
10.5.6.2.2 Argentina Recombinant Proteins Market by Application
10.5.6.2.3 Argentina Recombinant Proteins Market by End User
10.5.6.3 Rest of South and Central America Recombinant Proteins Market
10.5.6.3.1 Rest of South and Central America Recombinant Proteins Market by Product
10.5.6.3.2 Rest of South and Central America Recombinant Proteins Market by Application
10.5.6.3.3 Rest of South and Central America Recombinant Proteins Market by End User
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL RECOMBINANT PROTEINS MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. RECOMBINANT PROTEINS MARKET, KEY COMPANY PROFILES
13.1. CROWN BIOSCIENCE INC.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. PROSPEC-TANY TECHNOGENE LTD.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. BPS BIOSCIENCE, INC.
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. NOVOPROTEIN
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. PEPROTECH, INC.
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. ELI LILLY AND COMPANY
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. MERCK AND CO., INC.
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. PROTEINTECH GROUP
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. GENSCRIPT
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. GLAXOSMITHKLINE PLC
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Crown Bioscience Inc.
2. Prospec-Tany Technogene Ltd.
3. BPS Bioscience, Inc.
4. Novoprotein
5. PeproTech, Inc.
6. Eli Lilly and Company
7. Merck & Co., Inc.
8. Proteintech Group
9. GenScript
10. GlaxoSmithKline plc

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Life Sciences : READ MORE..